FRESENIUS MEDICAL CARE AG Revenue From Government Grants
FRESENIUS MEDICAL CARE AG (FMS) reported Revenue From Government Grants of EUR 3.99 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-02-20.
Discontinued › Income Statement › Other Income
ifrs-full:RevenueFromGovernmentGrants · last filed 2024-02-20
- FRESENIUS MEDICAL CARE AG revenue from government grants for the quarter ending 2023-12-31 was 409.00K EUR, a 95.64% decline year-over-year.
- FRESENIUS MEDICAL CARE AG revenue from government grants for the quarter ending 2023-09-30 was 883.00K EUR, a 99.06% decline year-over-year.
- FRESENIUS MEDICAL CARE AG revenue from government grants for the quarter ending 2023-06-30 was 988.00K EUR, a 99.39% decline year-over-year.
- FRESENIUS MEDICAL CARE AG revenue from government grants for the quarter ending 2023-03-31 was 1.71M EUR, a 90.62% decline year-over-year.
| Period end | Revenue From Government Grants 3 month | Revenue From Government Grants 6 month | Revenue From Government Grants 6 month as first filed | Revenue From Government Grants 9 month | Revenue From Government Grants 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | 409.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-20 | 1.29M EUR derived: sum of 2 quarters · filed 2024-02-20 | 2.28M EUR derived: sum of 3 quarters · filed 2024-02-20 | 3.99M EUR 20-F · filed 2024-02-20 | |
| 2023-09-30 | 883.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-02 | 1.87M EUR derived: sum of 2 quarters · filed 2023-11-02 | 3.58M EUR 6-K · filed 2023-11-02 | 12.96M EUR derived: sum of 4 quarters · filed 2024-02-20 | |
| 2023-06-30 | 988.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-08-02 | 2.69M EUR 6-K · filed 2023-08-02 | 12.08M EUR derived: sum of 3 quarters · filed 2024-02-20 | 106.03M EUR derived: sum of 4 quarters · filed 2024-02-20 | |
| 2023-03-31 | 1.71M EUR 6-K · filed 2023-05-09 | 11.09M EUR derived: sum of 2 quarters · filed 2024-02-20 | 105.04M EUR derived: sum of 3 quarters · filed 2024-02-20 | 268.26M EUR derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-12-31 | 9.39M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-20 | 103.34M EUR derived: sum of 2 quarters · filed 2024-02-20 | 266.55M EUR derived: sum of 3 quarters · filed 2024-02-20 | 284.74M EUR 20-F · filed 2024-02-20 | |
| 2022-09-30 | 93.95M EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-02 | 257.16M EUR derived: sum of 2 quarters · filed 2023-11-02 | 275.36M EUR 6-K · filed 2023-11-02 | 327.47M EUR derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | 163.21M EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-08-02 | 181.40M EUR 6-K · filed 2023-08-02 | 233.52M EUR derived: sum of 3 quarters · filed 2023-08-02 | 236.00M EUR derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-03-31 | 18.19M EUR 6-K · filed 2023-05-09 | 70.31M EUR derived: sum of 2 quarters · filed 2023-05-09 | 72.79M EUR derived: sum of 3 quarters · filed 2023-05-09 | 83.49M EUR derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | 52.12M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-22 | 54.60M EUR derived: sum of 2 quarters · filed 2023-02-22 | 65.30M EUR derived: sum of 3 quarters · filed 2023-02-22 | 72.53M EUR 20-F · filed 2023-02-22 | |
| 2021-09-30 | 2.49M EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-10-31 | 13.19M EUR derived: sum of 2 quarters · filed 2022-10-31 | 20.42M EUR 6-K · filed 2022-10-31 | 47.63M EUR derived: sum of 4 quarters · filed 2022-10-31 | |
| 2021-06-30 | 10.70M EUR derived: 6-K 6 month − 6-K 3 month · filed 2022-08-02 | 17.93M EUR 6-K · filed 2022-08-02 | 45.14M EUR derived: sum of 3 quarters · filed 2022-08-02 | 82.74M EUR derived: sum of 4 quarters · filed 2022-08-02 | |
| 2021-03-31 | 7.23M EUR 6-K · filed 2022-05-04 | 34.44M EUR derived: sum of 2 quarters · filed 2022-05-04 | 72.03M EUR derived: sum of 3 quarters · filed 2022-05-04 | ||
| 2020-12-31 | 27.21M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-02-22 | 64.81M EUR derived: sum of 2 quarters · filed 2022-02-22 | 251.66M EUR 20-F · filed 2022-02-22 | ||
| 2020-09-30 | 37.59M EUR derived: 6-K 9 month − 6-K 6 month · filed 2021-11-02 | 224.45M EUR 6-K · filed 2021-11-02 | |||
| 2020-06-30 | 186.86M EUR 6-K · filed 2021-07-30 | 181.53M EUR 6-K · filed 2020-07-30 |